Chris Rao Discusses the Impact of COVID-19 on Clinical Trials
Clinical trials have been heavily impacted by the COVID-19 crisis, affecting companies in all stages of development. Alira Health’s Christopher Rao, Vice President, Clinical Development, talks about the current disruption, the recently released FDA guidelines, and his best advice for companies who are in the midst of (or just starting) clinical trial work during this challenging time.
Download our latest report: COVID-19:
COVID-19: Monitoring Impacts and Anticipating Trends to Limit Downturn and Optimize Rebound